This is the direction I have been waiting for!!! While it may be a while and the outcome is unknown (as it is the case with ANY medical research venture), I am encouraged by the indications and this, in my PERSONAL opinion, is a natural direction for immutep. Of course, this does not take ANYTHING away from our current oncology ventures and opportunities, including AIPAC for that matter.
May not know for a while but, this sure is exciting and hopefully a game changer in its own right.
Ann: Immutep advances its LAG-3 agonist for autoimmune diseases, page-3
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $472.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.8¢ | 32.5¢ | $718.9K | 2.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 183899 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |